|
Recruiting
|
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
|
|
Recruiting
|
NCT05785468 -
A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)
|
|
|
Completed
|
NCT04074187 -
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
|
Phase 2/Phase 3 |
|
Terminated
|
NCT00953771 -
Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)
|
Phase 2 |
|
Recruiting
|
NCT01257269 -
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
|
|
|
Not yet recruiting
|
NCT05568147 -
Aspirin for Prophylaxis of TTP
|
Phase 2/Phase 3 |
|
Recruiting
|
NCT05468320 -
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
|
Phase 3 |
|
Completed
|
NCT00713193 -
Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
|
Phase 3 |
|
Completed
|
NCT00426686 -
ADAMTS13 in Thrombotic Thrombocytopenic Purpura
|
N/A |
|
Withdrawn
|
NCT00251277 -
Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
|
Phase 1/Phase 2 |
|
Recruiting
|
NCT04588194 -
Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
|
Phase 2 |
|
Active, not recruiting
|
NCT03237819 -
Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care
|
Phase 3 |
|
Completed
|
NCT00907751 -
Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
|
Phase 2 |
|
Completed
|
NCT03369314 -
Observational Study of the Use of octaplasLG®.
|
|
|
Terminated
|
NCT01938404 -
Octaplas Adult TTP Trial
|
|
|
Recruiting
|
NCT04981028 -
The ConNeCT Study: Neurological Complications of TTP
|
|
|
Completed
|
NCT02134171 -
Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
|
N/A |
|
Withdrawn
|
NCT02626663 -
The Role of Microparticles as a Biomarker
|
|
|
Completed
|
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
|
|
Terminated
|
NCT00593229 -
International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
|
N/A |